The Juravinski Hospital is a hospital in Hamilton, Ontario, Canada operated by Hamilton Health Sciences. It is located adjacent to the Juravinski Cancer Centre. The hospital was ranked 2nd in Canada for research according to Research Infosource Inc. in 2014.

There are 228 beds in Juravinski Hospital.

During the past decade, Juravinski Hospital conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 4 clinical trials were completed, i.e. on average, 6.6% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 3 clinical trials were completed. i.e. 8.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Juravinski Hospital" #1 sponsor was "McMaster University" with 32 trials, followed by "Hamilton Health Sciences Corporation" with 12 trials sponsored, "Population Health Research Institute" with 8 trials sponsored, "Ottawa Hospital Research Institute" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Juravinski Hospital" #1 collaborator was "Hamilton Health Sciences Corporation" with 17 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 12 trials as a collaborator, "St. Joseph's Healthcare Hamilton" with 7 trials as a collaborator, "McMaster University" with 4 trials as a collaborator and "The Physicians' Services Incorporated Foundation" with 4 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Juravinski Hospital" are "Venous Thromboembolism" (8 trials), "Breast Cancer" (7 trials), "Atrial Fibrillation" (5 trials), "Pulmonary Embolism" (4 trials) and "Hematoma Postoperative" (3 trials). Many other conditions were trialed in "Juravinski Hospital" in a lesser frequency.

Most popular intervention types in "Juravinski Hospital" are "Drug" (24 trials), "Other" (22 trials), "Device" (8 trials), "Procedure" (7 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Accelerated medical clearance and surgery" (2 trials), "Convalescent plasma" (2 trials), "Normal Saline" (2 trials) and "Placebo Oral Tablet" (2 trials). Other intervention names were less common.

The vast majority of trials in "Juravinski Hospital" are 61 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 33 active trials in "Juravinski Hospital". 5 are not yet recruiting, 21 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 31 completed trials in Juravinski Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Juravinski Hospital, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 24 trials that are defined as “Not Applicable".